Back to search
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours
Data up to Jan 2025
Published2009
Citations4
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...